AMPH icon

Amphastar Pharmaceuticals

218 hedge funds and large institutions have $1.13B invested in Amphastar Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

2% more funds holding

Funds holding: 213218 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 82

Holders
218
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23M
Puts
$581K
Net Calls
Net Calls Change

Top Buyers

1 +$20.1M
2 +$16.2M
3 +$11.7M
4
Millennium Management
Millennium Management
New York
+$9.23M
5
Bank of America
Bank of America
North Carolina
+$8.46M

Top Sellers

1 -$17.7M
2 -$12M
3 -$6.47M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.44M
5
Morgan Stanley
Morgan Stanley
New York
-$3.11M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$837K
102
$819K
103
$804K
104
$787K
105
$783K
106
$778K
107
$768K
108
$766K
109
$742K
110
$739K
111
$739K
112
$663K
113
$660K
114
$646K
115
$641K
116
$633K
117
$629K
118
$624K
119
$600K
120
$584K
121
$574K
122
$569K
123
$554K
124
$541K
125
$538K